Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway

Kidney Research and Clinical Practice

Volumn 31, Issue 3, 2012, Pages 177-185

  Cha, Jin Joo ^a   Hyun, Young Youl ^a   Jee, Yi Hwa ^b   Lee, Mi Jin ^a   Han, Kum Hyun ^c   Kang, Young Sun ^a   Han, Sang Youb ^c   Cha, Dae Ryong ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

Atherosclerosis; Diabetes mellitus; Leptin; Monocyte chemotactic peptide 1; Vascular smooth muscle cell

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; E26 LIKE TRANSCRIPTION FACTOR; GLUCOSE; HEMOGLOBIN A1C; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ALBUMINURIA; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BODY MASS; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIET RESTRICTION; ENZYME PHOSPHORYLATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; LEPTIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 84879193006     PISSN: 22119132     EISSN: 22119140     Source Type: Journal    
DOI: 10.1016/j.krcp.2012.06.004     Document Type: Article

References (31)

1. R.H. Eckel, S.M. Grundy, and P.Z. Zimmet The metabolic syndrome Lancet 365 2005 1415 1428
2. D.C. Lau, B. Dhillon, H. Yan, P.E. Szmitko, and S. Verma Adipokines: molecular links between obesity and atheroslcerosis Am J Physiol Heart Circ Physiol 288 2005 H2031 H2041
3. A. Rudijanto The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis Acta Med Indones 39 2007 86 93
4. J.D. McGarry Appetite control: Does leptin lighten the problem of obesity? Curr Biol 5 1995 1342 1344
5. F. Huang, X. Xiong, H. Wang, S. You, and H. Zeng Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1/2 and NF-kappaB Acta Biochim Biophys Sin (Shanghai) 42 2010 325 331
6. A. Oda, T. Taniguchi, and M. Yokoyama Leptin stimulates rat aortic smooth muscle cell proliferation and migration Kobe J Med Sci 47 2001 141 150
7. K.E. Wellen, and G.S. Hotamisligil Obesity-induced inflammatory changes in adipose tissue J Clin Invest 112 2003 1785 1788
8. H. Kanda, S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, R. Kitazawa, S. Kitazawa, H. Miyachi, S. Maeda, K. Egashira, and M. Kasuga MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity J Clin Invest 116 2006 1494 1505
9. N. Kamei, K. Tobe, R. Suzuki, M. Ohsugi, T. Watanabe, N. Kubota, N. Ohtsuka-Kowatari, K. Kumagai, K. Sakamoto, M. Kobayashi, T. Yamauchi, K. Ueki, Y. Oishi, S. Nishimura, I. Manabe, H. Hashimoto, Y. Ohnishi, H. Ogata, K. Tokuyama, M. Tsunoda, T. Ide, K. Murakami, R. Nagai, and T. Kadowaki Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance J Biol Chem 281 2006 26602 26614
10. I.F. Charo, and R.M. Ransohoff The many roles of chemokines and chemokine receptors in inflammation N Engl J Med 354 2006 610 621
11. Y. Sheikine, and G.K. Hansson Chemokines and atherosclerosis Ann Med 36 2004 98 118
12. I.F. Charo, and M.B. Taubman Chemokines in the pathogenesis of vascular disease Circ Res 95 2004 858 866
13. A.C. Doran, N. Meller, and C.A. McNamara Role of smooth muscle cells in the initiation and early progression of atherosclerosis Arterioscler Thromb Vasc Biol 28 2008 812 819
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl 1 2003 S5 S20
15. K. Kishida, T. Funahashi, and I. Shimomura Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease - Lesson from the Amagasaki Visceral Fat Study: A Japanese perspective Nutr Metab (Lond) 8 2011 57
16. A.W Jr. Ferrante Obesity-induced inflammation: a metabolic dialogue in the language of inflammation J Intern Med 262 2007 408 414
17. H. Kastarinen, Y.A. Kesäniemi, and O. Ukkola Leptin and lipid metabolism in chronic kidney failure Scand J Clin Lab Invest 69 2009 401 408
18. CS Mantzoros, F. Magkos, M. Brinkoetter, E. Sienkiewicz, TA Dardeno, SY Kim, OP Hamnvik, and A Koniaris Leptin in human physiology and pathophysiology Am J Physiol Endocrinol Metab 301 2011 E567 E584
19. F. Zhang, Y. Chen, M. Heiman, and R. Dimarchi Leptin: structure, function and biology Vitam Horm 71 2005 345 372
20. A. Stofkova Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity Endocr Regul 43 2009 157 168
21. F. Bohlen, J. Kratzsch, M. Mueller, B. Seidel, M. Friedman-Einat, H. Witzigmann, D. Teupser, A. Koerner, M. Storck, and J. Thiery Leptin inhibits cell growth of human vascular smooth muscle cells Vascul Pharmacol 46 2007 67 71
22. A.M. Wallace, A.D. McMahon, C.J. Packard, A. Kelly, J. Shepherd, A. Gaw, and N. Sattar Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS) Circulation 104 2001 3052 3056
23. M.P. Reilly, N. Iqbal, M. Schutta, M.L. Wolfe, M. Scally, A.R. Localio, D.J. Rader, and S.E. Kimmel Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes J Clin Endocrinol Metab 89 2004 3872 3878
24. H. Hasan-Ali, N.A. Abd El-Mottaleb, H.B. Hamed, and A. Abd-Elsayed Serum adiponectin and leptin as predictors of the presence and degree of coronary atherosclerosis Coron Artery Dis 22 2011 264 269
25. P.F. Bodary, S. Gu, Y. Shen, A.H. Hasty, J.M. Buckler, and D.T. Eitzman Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 25 2005 e119 e122
26. L. Piemonti, G. Calori, A. Mercalli, G. Lattuada, P. Monti, M.P. Garancini, F. Costantino, G. Ruotolo, L. Luzi, and G. Perseghin Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality Diabetes Care 26 2003 2883 2889
27. G. Hoefle, C.H. Saely, L. Risch, P. Rein, L. Koch, F. Schmid, T. Aczel, T. Marte, P. Langer, and H. Drexel Leptin, leptin soluble receptor and coronary atherosclerosis Eur J Clin Invest 37 2007 629 636
28. L. Li, J.C. Mamputu, N. Wiernsperger, and G. Renier Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin Diabetes 54 2005 2227 2234
29. E.R. Isenovic, M.H. Kedees, M.A. Haidara, A. Trpkovic, D.P. Mikhailidis, and P. Marche Involvement of ERK1/2 kinase in insulin-and thrombin-stimulated vascular smooth muscle cell proliferation Angiology 61 2010 357 364
30. M. Allman, M. Wallace, L. Gaskin, and C.A. Rivera Leptin induces an inflammatory phenotype in lean Wistar rats Mediators Inflamm 2009 2009 738620
31. S. Aleffi, I. Petrai, C. Bertolani, M. Parola, S. Colombatto, F. Novo, E. Vizzutti, FA Anania, S. Milani, K. Rombouts, G. Laffi, M. Pinzani, and F. Marra Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells Hepatology 42 2005 1339 1348